<DOC>
	<DOCNO>NCT01090531</DOCNO>
	<brief_summary>This observational long-term follow-up study evaluate demographic , clinical , histological , biochemical , virological parameter patient chronic hepatitis B low viremia require antiviral therapy accord current guideline . Liver stiffness value detect FibroScan ARFI also collect available . All data collect yearly interval ( minimum ) . Patients include study follow 10 year . The target sample size &lt; 1000 .</brief_summary>
	<brief_title>Patients With Chronic Hepatitis B Low Viremia Not Receiving Antiviral Therapy</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Hepatitis B , Chronic</mesh_term>
	<mesh_term>Viremia</mesh_term>
	<mesh_term>Antiviral Agents</mesh_term>
	<criteria>adult patient , age 1879 chronic hepatitis B HBVDNA &lt; 100.000 IU/ml ALT â‰¤2 x ULN recent liver histology and/or FibroScan measurement willingness sign inform consent current past antiviral therapy hepatitis B chronic hepatitis B immune tolerance phase ( HBeAg positive , high viral load ) coinfection HIV , HCV malignant disease HCC liver tumor</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>May 2012</verification_date>
</DOC>